Journal
Jornal
RDF description of ALLERGY (COPENHAGEN) - https://brcris.ibict.br/individual/journ_f8bd1b1b-c911-4194-8e1a-4446087c95d9
Differentiation of COVID¿19 signs and symptoms from allergic rhinitis and common cold¿ An ARIA¿EAACI¿GA LENconsensus
Correlation between work impairment, scores of rhinitis severity and asthma using the MASK¿air App
In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy
Rhinitis associated with asthma is distinct from rhinitis alone: The hypothesis
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
Characteristics of patients with severe allergic asthma according to atopic multimorbidity
Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE study
Allergic and hypersensitivity conditions in non¿specialist care: Flow¿diagrams to support clinical practice
Different phenotypes of drug-induced anaphylaxis-Data from the European Anaphylaxis Registry
Arginase inhibitors: An alternative in treatment of obese asthma?
Management of anaphylaxis due to COVID-19 vaccines in the elderly.
Hypersensitivities following allergen antigen recognition by unconventional T cells
Presence of angioedema in chronic urticaria and montelukast response
Impact of early life geohelminths on wheeze, asthma and atopy in Ecuadorian children at 8 years
Global implementation of the world health organization?s international classification of diseases (ICD)¿11: the allergic and hypersensitivity conditions model
Vasculitis in patients with chronic urticaria or autoimmune disease
Comparison of rhinitis treatments using -air® data and considering the minimal important difference
Adrenaline autoinjector is underprescribed in typical cold urticaria patients
Asthmatic patients and COVID-19: Different disease course?
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.
Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study
The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update
n vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy [Internet]
ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020)
Influence of emotional stress on clinical presentation of chronic urticaria patient
N¿terminal peptide deletion influences immunological and structural features of Blo t 5
Definition, aims, and implementation of GA 2 LEN/HAEi Angioedema Centers of Reference and Excellence
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2 LEN consensus.
The effects of climate change on respiratory allergy and asthma induced by pollen and mold allergens
Consistent trajectories of rhinitis control and treatment in 16,177-weeks: The -air® longitudinal study
Anaphylaxis during skin prick test with aeroallergen extract: Case report
The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
Development and validation of combined symptom-medication scores for allergic rhinitis*
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice
Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper
<scp>IgG</scp> memory B cells expressing IL4R and FCER2 are associated with atopic diseases
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air real-world data
Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
Genetic Variants Associated with T¿Cell Mediated Cutaneous Adverse Drug Reactions: A Prisma¿Compliant Systematic Review - an EAACI Position Paper
Presentation of airway and general symptoms in Covid¿19 caused by dominant SARS¿CoV¿2 variants: a follow¿up on ARIA consensus